β-内酰胺类过敏状态对手术部位感染率的影响:回顾性队列研究
单中心回顾性队列分析2676例手术,报告β-内酰胺类过敏者454例(17%),非β-内酰胺类过敏者2222例(83%)。β-内酰胺类过敏组手术部位感染率显著高于非过敏组(3.1% vs 1.5%,OR 2.015,95%CI 1.090-3.724,P=0.023)。多因素回归显示接受非β-内酰胺类抗生素方案是SSI率唯一显著影响因素(aOR 3.815,95%CI 1.142-12.749,P=0.030)。
要点
- 报告β-内酰胺类过敏者SSI风险约为非过敏者的2倍。
- 接受非β-内酰胺类抗生素方案与SSI风险升高独立相关。
- 详细采集抗生素过敏史有助于安全增加β-内酰胺类方案使用。
核心结论
- 报告β-内酰胺类过敏的患者相比非β-内酰胺类过敏患者,发生手术部位感染的 odds 增加。
- 该风险增加可能与使用非β-内酰胺类抗生素方案而非β-内酰胺类方案有关。
研究设计与样本
- 单中心回顾性队列研究,纳入剖宫产、经阴道及腹式子宫切除术、结肠手术、椎板切除术和脊柱融合术等目标手术。
- 共分析2676例手术,报告β-内酰胺类过敏组454例(17%),非β-内酰胺类过敏组2222例(83%)。
主要发现
- β-内酰胺类过敏组SSI发生率3.1%,非过敏组1.5%,OR 2.015(95%CI 1.090-3.724,P=0.023)。
- 多因素logistic回归中,接受非β-内酰胺类抗生素方案是唯一对SSI率有显著影响的变量(aOR 3.815,95%CI 1.142-12.749,P=0.030)。
临床怎么用
- 对报告β-内酰胺类过敏的患者,应详细采集抗生素过敏史以评估真实性。
- 通过准确过敏史评估,可安全提高接受β-内酰胺类方案预防的比例,作为SSI预防工具。
局限性
- 单中心回顾性设计可能限制结果外推性。
- 过敏状态基于患者报告,可能存在错分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine if patients with reported BL allergies have increased odds of developing SSI compared to reported NBL allergic patients. SUMMARY OF BACKGROUND DATA: SSI represent a significant risk of morbidity and mortality for patients. Cefazolin-based perioperative antibiotic prophylaxis is the guideline-recommended drug-of-choice for most procedures. Due to over-reporting of BL allergies, many patients may not receive guideline-directed cephalosporin-based prophylaxis, which may result in an increased SSI rate. METHODS: A single-center retrospective cohort design study was performed. Data was collected on all targeted surgical procedures: cesarean section, vaginal, and abdominal hysterectomy, colon, laminectomy, and spinal fusion surgeries. RESULTS: During the study period, 2676 procedures were analyzed with 454 (17%) and 2222 (83%) in reported BL and NBL allergic cohorts, respectively. Significantly more SSI developed in the BL cohort versus NBL cohort (3.1% vs 1.5%, odds ratio 2.015; 95% confidence interval, 1.090-3.724; P = 0.023). Through a multivariate logistic regression, receipt of a NBL antibiotic regimen was the only variable to have a significant effect on SSI rate (adjusted odds ratio, 3.815; 95% confidence interval, 1.142-12.749; P = 0.030). CONCLUSION: Reported BL allergic patients have an increased odds of developing SSI in comparison to NBL allergic patients. The increased risk is likely related to administration of NBL antibiotic regimens in comparison to BL-based regimens. Thorough antibiotic allergy history collection can be a valuable SSI prevention tool to safely increase the proportion of patients receiving BL regimen.
引用
- Wilhelm NB, Bonsall TJ, Miller CL, et al. The Effect of Beta-lactam Allergy Status on the Rate of Surgical Site Infections: A Retrospective Cohort Study. Ann Surg. 2022. PMID: 32502079. doi:10.1097/SLA.0000000000003949
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。